Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radlotrequency Ablation

Peng Zhenwei; Chen Shuling; Wei Mengchao; Lin Manxia; Jiang Chunlin; Mei Jie; Li Bin; Wang Yu; Li Jiaping; Xie Xiaoyan; Chen Minshan; Qian Guojun; Kuang Ming

首页> 外文期刊>Radiology >Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radlotrequency Ablation

【24h】

Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radlotrequency Ablation

机译：先进的复发性肝细胞癌：用索拉非尼治疗单独或与横冲化疗栓塞和radlotQuency消融组合

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To retrospectively investigate the safety and efficacy of sorafenib combined with transarterial chemoembolization (TACE) and racliofrequency ablation (RFA) (hereafter. TACE-RFA) in the treatment of recurrent hepatocellular carcinoma (rHCC) with portal vein tumor thrombosis, extrahepatic metastases (advanced hepatocellular carcinoma), or both after initial hepatectomy.

机译：目的：回顾性研究索拉非尼与ransarien echoybolization（TACE）和rFA）（RFA）（TACE-RFA）与门静脉肿瘤血栓形成，脱毛转移（先进的肝细胞癌），或初始肝切除术后。

著录项

来源
《Radiology》 |2018年第2期|共10页
作者
Peng Zhenwei; Chen Shuling; Wei Mengchao; Lin Manxia; Jiang Chunlin; Mei Jie; Li Bin; Wang Yu; Li Jiaping; Xie Xiaoyan; Chen Minshan; Qian Guojun; Kuang Ming;
展开▼
作者单位

Sun Yat Sen Univ Affiliated Hosp 1 Dept Oncol 58 Zhongshan Rd 2 Guangzhou 510080 Guangdong;

Sun Yat Sen Univ Affiliated Hosp 1 Div Intervent Ultrasound 58 Zhongshan Rd 2 Guangzhou 510080;

Sun Yat Sen Univ Affiliated Hosp 1 Dept Liver Surg 58 Zhongshan Rd 2 Guangzhou 510080;

Sun Yat Sen Univ Affiliated Hosp 1 Div Intervent Ultrasound 58 Zhongshan Rd 2 Guangzhou 510080;

Sun Yat Sen Univ Affiliated Hosp 1 Div Intervent Ultrasound 58 Zhongshan Rd 2 Guangzhou 510080;

Sun Yat Sen Univ Affiliated Hosp 1 Clin Trials Unit 58 Zhongshan Rd 2 Guangzhou 510080;

Sun Yat Sen Univ Affiliated Hosp 1 Clin Trials Unit 58 Zhongshan Rd 2 Guangzhou 510080;

Sun Yat Sen Univ Affiliated Hosp 1 Dept Intervent Oncol 58 Zhongshan Rd 2 Guangzhou 510080;

Sun Yat Sen Univ Affiliated Hosp 1 Dept Intervent Oncol 58 Zhongshan Rd 2 Guangzhou 510080;

Sun Yat Sen Univ Affiliated Hosp 1 Div Intervent Ultrasound 58 Zhongshan Rd 2 Guangzhou 510080;

Sun Yat Sen Univ Canc Ctr Dept Hepatobiliary Surg Guangzhou Guangdong Peoples R China;

Second Mil Med Univ Affiliated Eastern Hepatobiliary Surg Hosp Dept Minimal Invas Therapy;

Sun Yat Sen Univ Affiliated Hosp 1 Div Intervent Ultrasound 58 Zhongshan Rd 2 Guangzhou 510080;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radlotrequency Ablation [J] . Peng Zhenwei, Chen Shuling, Wei Mengchao, Radiology . 2018,第2期

机译：先进的复发性肝细胞癌：用索拉非尼治疗单独或与横冲化疗栓塞和radlotQuency消融组合
2. Sorafenib in combination with transarterial chemoembolization and radiofrequency ablation in the treatment for unresectable hepatocellular carcinoma [J] . Medical oncology . 2013,第4期

机译：索拉非尼联合经动脉化学栓塞和射频消融治疗无法切除的肝细胞癌
3. Combination therapy of radiofrequency ablation and transarterial chemoembolization in recurrent hepatocellular carcinoma after hepatectomy compared with single treatment. [J] . Yang W, Chen MH, Wang MQ, Hepatology research: the official journal of the Japan Society of Hepatology . 2009,第3期

机译：肝切除术后复发性肝细胞癌的射频消融联合经动脉化学栓塞治疗与单药治疗相比。
4. Improved quantitative contrast-enhanced ultrasound imaging of hepatocellular carcinoma response to transarterial chemoembolization [C] . Ipek Oezdemir, Collette Shaw, John R. Eisenbrey, IEEE International Symposium on Biomedical Imaging . 2019

机译：改进的肝细胞癌对经动脉化疗栓塞反应的定量对比增强超声成像
5. Sesquiterpene drugs as potential treatment for hepatocellular carcinoma (HCC): Preclinical evaluation of parthenolide administered via transarterial chemoembolization in a rat HCC tumor model. [D] . Chen, Zheng. 2016

机译：倍半萜类药物可作为肝细胞癌（HCC）的潜在治疗方法：在大鼠HCC肿瘤模型中，通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
6. Large hepatocellular carcinoma with local remnants after transarterial chemoembolization: treatment by sorafenib combined with radiofrequency ablation or sorafenib alone [O] . Hongjun Yuan, Yina Lan, Xin Li, 2019

机译：经大动脉化疗栓塞后局部残留的大型肝细胞癌：索拉非尼联合射频消融或单用索拉非尼治疗
7. Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation [O] . Zhenwei Peng, Shuling Chen, Mengchao Wei, 2018

机译：先进的复发性肝细胞癌：单独用索拉非尼治疗或与龙霉栓塞和射频消融组合

Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radlotrequency Ablation

摘要

著录项

相似文献

相关主题

期刊订阅